Cargando…

Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer

Detalles Bibliográficos
Autores principales:	Elia, Androulla, Lincoln, Louise, Brunet, Laura Rosa, Hagemann, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991081/ http://dx.doi.org/10.1186/2051-1426-1-S1-P215

Ejemplares similares

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
por: Bilyard, Hilary, et al.
Publicado: (2014)

A role for immunotherapy: preventing macrophage anergy in the tumour environment
por: Elia, Androulla, et al.
Publicado: (2013)

ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing
por: Donnellan, Zoe, et al.
Publicado: (2015)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Identification of circulatory biomarkers from clinical trial samples
por: Brunet, Laura Rosa, et al.
Publicado: (2015)

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells
por: Boudousquie, Caroline, et al.
Publicado: (2017)

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer
por: van ‘t Land, Freek R., et al.
Publicado: (2022)

Changes in immune checkpoint protein expression on CD8 T cells during neoadjuvant therapy in patients with pancreatic cancer
por: Tsai, Susan, et al.
Publicado: (2014)

The HIV-1 protective -35SNP effect in Caucasians is CD8 T cell mediated
por: Corrah, T, et al.
Publicado: (2012)

Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)

Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and a Novel Immunotherapy Agent, IMM-101
por: Costa Neves, Mafalda, et al.
Publicado: (2015)

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015)

What drives a normal relation between T-CD4 and T-CD8?
por: Badura, R, et al.
Publicado: (2010)

Guidelines for chest drain insertion do not protect relevant anatomical structures
por: Bowness, J, et al.
Publicado: (2013)

P101: Product dose considerations for real-world hand sanitiser efficacy
por: Hines, J, et al.
Publicado: (2013)

P101: GUT MICROBIOTA IMPACT ON ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
por: Brito, M, et al.
Publicado: (2022)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Tumor derived exosome induction of the CD3+CD8+ T cell tolerogenic phenotype
por: Maybruck, Brian, et al.
Publicado: (2013)

Upregulation of neuroreceptors on CD4+ and CD8+ T cells promotes their anti-tumor function
por: de Aquino, Maria Teresa, et al.
Publicado: (2015)

Maturation of protective immunity induced by SIVΔnef correlates with differential expression of transcription factors in SIV-specific CD8+ T cells
por: Billingsley, JM, et al.
Publicado: (2012)

Protection from liver-stage malaria is dependent on a fine balance between the number of infected hepatocytes and effector CD8(+) T cells
por: Spencer, Alexandra, et al.
Publicado: (2014)

Alloantigenic recognition properties of CD8(+) regulatory T cells
por: Picarda, Elodie, et al.
Publicado: (2011)

ELISPOTs produced by CD8 and CD4 cells follow log normal size distribution
por: Ghosh, Jaya, et al.
Publicado: (2013)

P02.101. Vitamin D status of female healthcare employees of childbearing age
por: Plotnikoff, G, et al.
Publicado: (2012)

AB101. Therapeutic effect of low intensity pulsed ultrasound in stress urinary incontinence
por: Yang, Bicheng, et al.
Publicado: (2016)

CD47 antibody inhibits tumor recurrence in a clinical relevant glioblastoma animal model
por: Zhu, Huaiyang, et al.
Publicado: (2015)

Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2013)

Baseline CD8 T-cell activation is not associated with survival in ATLL
por: Taylor, Graham P, et al.
Publicado: (2015)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
por: Hamimi, C, et al.
Publicado: (2012)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

P-101: REMEDIAL EFFECT OF GUDUCHI SATWA IN SICKLE RED BLOOD CELLS – AN AYURVEDIC APPROACH
por: A., RAJESH, et al.
Publicado: (2022)

Re-measurement of $^{32}$Ar to test the IMME
por: Kreim, S
Publicado: (2012)

Clonality of HTLV-1 differs between infected CD8+ T cells and infected CD4+ T cells in vivo
por: Melamed, Anat, et al.
Publicado: (2014)

A role for CD8 cells in cell-contact-mediated inflammation
por: Robertson, SE, et al.
Publicado: (2005)

Frequency and function of KIR(+) CD8(+) T cells in HTLV-1 infection
por: Twigger, Katie, et al.
Publicado: (2014)

Characterization of Flucloxacillin-specific CD8+ T-cells in a mouse model
por: Nattrass, Ryan, et al.
Publicado: (2014)

How frequently are predicted peptides actually recognized by CD8 cells?
por: Sundararaman, Srividya, et al.
Publicado: (2013)

Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)

Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ddo5au5fkb4c30pspubop9t0na